Principal Investigator
Hakop Gevorkyan, MD, MBA
California Clinical Trials Medical Group
- 2 trials
- 1 compound
Therapeutic focus
- Cognitive Dysfunction
- Schizophrenia
- Alzheimer's Disease
All trials (2)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06225115 | Phase 1 | Completed | KYN-5356 | Kynexis B.V. |
| NCT02221947 | Phase 1/2 | Discontinued | — | Neurotrope Bioscience, Inc. |
Compounds studied
Trial sites (1)
- Glendale, California, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).